mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.0002 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0002 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0003 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0003 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0004 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0004 |
mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
-0.2 |
0.0005 |